Karim Fizazi
卡里姆·菲扎齐
MD, PhD
Professor and Head, Department of Cancer Medicine癌症医学科主任教授
👥Biography 个人简介
World-leading GCT clinician-scientist at Institut Gustave Roussy, France's premier cancer center. Renowned for elucidating GCT molecular biology, leading pivotal trials for poor-risk and refractory GCT, and developing miRNA biomarkers. Chairs ESMO GCT guidelines and leads international collaborative studies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Poor-Risk GCT Treatment Intensification
Led international trials (BEP intensification, dose-dense schedules) for poor-risk GCTs, and co-designed the GETUG P01 and IT-94 trials to improve outcomes in this challenging population.
GCT Molecular Biology
Elucidated mechanisms of cisplatin sensitivity in GCTs through studies of p53, stem cell transcription factors, and epigenetic regulators, identifying determinants of chemosensitivity and resistance.
Residual Mass Management After Chemotherapy
Defined criteria and outcomes for post-chemotherapy resection of residual masses including mature teratoma, necrosis, and viable tumor, informing surgical decision-making worldwide.
Representative Works 代表性著作
Randomized Phase III Trial of BEP Versus Dose-Dense BEP in Poor-Risk GCT
Journal of Clinical Oncology (2014)
Demonstrated that dose-dense BEP did not improve outcomes vs. standard BEP in poor-risk GCT, establishing that intensification of BEP alone is insufficient.
Necrosis Following Chemotherapy in GCTs: Predictors and Outcomes
Journal of Clinical Oncology (2001)
Landmark analysis of residual mass histology predictors, establishing the Indiana University / IGR model for surgical decision-making post-BEP.
Updated Prognostic Factor-Based Risk Group Classification for Metastatic GCT
Journal of Clinical Oncology (2021)
IGCCCG 2021 update refining prognostic classification using contemporary data from 13,000+ patients, improving risk stratification accuracy.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 卡里姆·菲扎齐 的研究动态
Follow Karim Fizazi's research updates
留下邮箱，当我们发布与 Karim Fizazi（Institut Gustave Roussy）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment